Clinical Trial Update: Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis [Phase 3]

View source ↗

Summary

Takeda's Phase 3 continuation study of Zasocitinib in adults with psoriatic arthritis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Zasocitinib (Zasocitinib)

Snippet

Sponsor: Takeda | Conditions: Psoriatic Arthritis | Phase 3 | Status: RECRUITING